KRISTYN FOX: Open Payments
NPI 1326670100 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 21 payments from 10 companies in 2025. Trend: 2023 $466 · 2024 $1,268 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $175 |
| ABBVIE INC. | 5 | $161 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $42 |
| Alkermes, Inc. | 1 | $26 |
| Collegium Pharmaceutical, Inc. | 1 | $22 |
| Neos Therapeutics, LP | 1 | $17 |
Products named: COBENFY, VRAYLAR, REXULTI, INGREZZA, CAPLYTA, Auvelity, ARISTADA, Jornay PM.
Industry payments across VA — which companies pay providers there.
